FY2025 (April 1, 2024 - March 31, 2025)

(Millions of Yen)

Takara Holdings

Inc.

(Consolidated)

y-o-

y(%)

Takara

Shuzo

y-o-

y(%)

Takara

Shuzo

International

Group

y-o-

y(%)

Takara

Bio

Group

y-o-

y(%)

Sales to customer

362,693

106.9%

119,663

96.7%

185,803

115.8%

45,039

103.5%

Cost of sales

243,045

107.8%

89,744

97.5%

126,108

116.0%

18,972

114.3%

Gross profit

119,647

105.0%

29,919

94.3%

59,694

115.4%

26,067

96.9%

SG&A expenses

99,050

108.0%

24,881

94.9%

48,038

121.9%

23,804

99.6%

Operating income

20,597

92.6%

5,037

91.5%

11,655

94.8%

2,263

75.4%

Non-operating

income

2,977

137.8%

449

115.7%

1,289

267.0%

619

120.5%

Non-operating

expenses

1,394

130.8%

312

121.8%

934

130.6%

289

259.8%

Ordinary income

22,180

95.0%

5,175

91.8%

12,010

99.6%

2,592

76.1%

Extraordinary gain

4,734

117.4%

696

-

20

47.7%

6

207.1%

Extraordinary loss

1,099

97.1%

434

85.1%

59

90.6%

601

108.5%

Income before

income taxes and

minority interests

25,815

98.4%

5,437

105.6%

11,971

99.5%

1,997

70.0%

Net income

attributable to

owners of the parent

16,202

100.2%

3,763

105.9%

7,475

100.3%

1,041

70.4%

――――

――――

――――

――――

――――

――――

――――

――――

――――

Research and

development

expenses

7,309

83.8%

400

102.3%

0

-

6,897

82.9%

Capital

expenditures

20,783

94.8%

4,135

100.7%

4,451

67.2%

10,106

92.2%

Depreciation

10,347

103.5%

2,773

107.2%

3,520

134.4%

3,611

84.4%

Amortization of

goodwill

1,727

146.4%

0

-

1,036

192.2%

690

107.8%